The buzz around cannabis in beauty and wellness
and is forecast to reach $63.5 billion by 2024, a
Opinion
The enduring virtue of CVS’ tobacco ban
a bold departure for a pharmacy chain in this country, one that sadly has yet to be matched by any of the company’s peers — was intended to discourage smokers from indulging in a habit that is clearly
Sansone’s retirement marks the end of an era
The news out of Rhode Island that Judy Sansone, chief merchant at CVS Pharmacy, will shortly retire signals more than the end of a remarkable and productive retail career.
TSE unites the industry for a powerful experience
In a recent column, Chain Drug Review editor David Pinto described the 2019 NACDS Annual Meeting this way: “In an ever-changing retail universe, a world where today’s bright hope is tomorrow’s used-to-be, the [NACDS] Annual Meeting, held each spring, remains the standard by which retail meetings are
Cannabis-based product rules continue to vary
the use of marijuana in plant form or its basic extracts. Although some states have legalized its use, the Food and Drug Administration has not approved marijuana in plant
‘Retail inspired’ strategies can help to save pharmacy
The last three years have been very tough for retail pharmacies.
Pharmacies excel as resource for specialty patients
As specialty drugs grow in importance and prominence, this is an ideal moment to consider the essential and evolving roles retail pharmacies play in this significant health care category.
Patient data: seeking to balance access and security
The continued digitization of electronic health records (EHRs) and growth in the number of wearables and Internet of Things (IoT) devices are rapidly expanding the volume of patient data.
Prescription-to-O-T-C switches are a win all around
Now is the time for Food and Drug Administration reforms designed to dramatically increase the number of prescription-to-O-T-C switches in the U.S.
Data can help pharmacists navigate the generics minefield
Perhaps the best way to begin the complicated story of generic drugs, and how using a data-based approach could help pharmacists, is to tell a bit about the rise of generics.
Rx school grads may still need O-T-C education
In Dr. Seuss’ (Theodor Geisel’s) last major book, Oh, the Places You’ll Go!, he put forth advice for recent graduates from almost any school: You have brains in your head. You have feet in your shoes. You can steer yourself. Any direction you choose. And you’re on your own.
Reaching out to consumers to improve their health
In 2018, five national pharmacy associations and a growing number of state associations launched Pharmacists for Healthier Lives, (PfHL), a public education campaign targeting influential groups of consumers and health professionals.
Three critical issues to focus on in Boston
legal proceedings in which it is asserted that retailers and drug wholesalers bear at least some responsibility for the ongoing opioid epidemic; the emergence of
Women executives excel as well as succeed
or perhaps not so — was that these award winners were all women. They
Change is coming to the dysfunctional payment model
Titration. In chemistry, it’s adding a reactant to a solution until a chemical reaction is achieved. The titration process might take numerous drops of reactant before its concentration is high enough to observe a noticeable change.
Best ideas aren’t always (or often) from Washington
Earlier this spring, the National Pharmaceutical Council (NPC) partnered with the Healthcare Leadership Council to hold town hall meetings in Raleigh, N.C., and Nashville. We asked health care leaders in those communities what really matters to them.